You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | -5,491.7% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | 0.6 | n/a |
PEG | -0.1 | n/a |
Price / Revenue | 57.0 | n/a |
Price / Book value | 1.6 |
Latest | Forecast | |
---|---|---|
Revenue | -7.7% | 0.0% |
PBT | 0.0% | n/a |
EPS | -5.2% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2018-12-31 | 0.08 | -7.96 | -5.19p | -2.3 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | 0.08 | -6.74 | -3.99p | -4.0 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | 0.13 | -7.25 | 3.43p | 3.9 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 0.12 | -8.94 | 3.25p | 2.0 | -0.4 | -5% | n/a | 0.0% |
ImmuPharma upbeat after meeting with US partner Avion Sharecast News | 11 Nov |
---|---|
ImmuPharma's US partner receives FDA response on Lupuzor Sharecast News | 14 Sep |
ImmuPharma making final preparations for Lupuzor phase 3 trial Sharecast News | 04 May |
Lupuzor™ Update | 27-Mar-23 14:40 |
---|---|
Price Monitoring Extension | 09-Mar-23 23:59 |
Collaboration with Orano on ImmuPharma Peptide | 06-Mar-23 15:04 |
Lupuzor™ Update | 06-Feb-23 14:15 |
TR-1: Notification of major holdings | 27-Jan-23 23:59 |